Group 16-20

Question 1

what ia biomea fusion

Answer 1

clinical stage biopharmaceutical company developing oral covalent small molecule inhibitors to treat cancers and metabolic diseases

Question 2

what is the platform of biomea fusion

Answer 2

built their own fusion system platform ro develop treatments against high value oncogenic drivers

Question 3

what is coherus bioscience

Answer 3

revenue stage, fully integrated biopharma

Question 4

what is the platform of coherus biosciences

Answer 4

biosimilar development and immuno-oncology therapeutics

Question 5

what is alx oncology

Answer 5

clinical stage immuno oncology

Question 6

what is the platform of alx oncology

Answer 6

next gen cd47 blocking therapeutics

Question 7

what is immunity bio inc

Answer 7

clinical stage biotech company

Question 8

what is the platform of immunity bioinc

Answer 8

usage of combination therapies focusing on the enhancement of the immune system to treat various infectious and oncological diseases

Question 9

what is omni ab

Answer 9

service based biotech company that will partner with pharmaceutical companies to generate thepapeutics

Question 10

what is the platform of omni ab

Answer 10

Transgenic animal technology to produce human antibodies
* OmniRat, Omnimouse, OmniChicken, OmniTaur, OmniClic, OmniFlic, OmnidAb

Question 11

what is tango therapeutics

Answer 11

clinical stage biotech committed to discovering novel drug targets and developing next gen of precision meds for the treatment of cancer

Question 12

what is the platform of tango therapeutics

Answer 12

synthetic lethality for targeting specific tumor suppressor gene loss

Question 13

what is halozyme therapeutics

Answer 13

clinical stage drug delivery platform biopharmaceutical company

Question 14

what is the platform for halozyme therapeutics

Answer 14

enhanze drug delivery tech for subcutaneous administration of injected drugs

Question 15

what is inhibrx

Answer 15

single domain antibody (sdAb) platform foundation to build novel drugs that target a variety of cancers (chondrosarcomas, nonsmall cell lung cancer, head/neck cancer) and alpha 1 antitrypsin (AAT) deficiency, which affects the lungs

Question 16

what is the platform of inhibrx

Answer 16

core sdAb platform is composed of camelid-derived heavy-chain-only antibodies that are miniaturized into sdAbs

Question 17

what is indeaya biosciences

Answer 17

precision medecine focused, clinical stage biotech focusing on targeted therapied for cancer treatment

Question 18

what is the platform of ideaya therapies

Answer 18

Synthetic Lethality (SL), as shown in the figure above, is a drug development strategy that targets specific genetic interactions between two
genes to selectively kill cancer cells by exploiting vulnerabilities created by the loss or mutation of certain genes that occurred exclusively in cancer cells.

Question 19

what is insmed inc biopharma platform

Answer 19

integration of early-stage research platforms, gene therapy, RNA End-Joining, protein deimmunization,
synthetic rescue and proprietary manufacturing.

Question 20

what is ironwood

Answer 20

leading gastrointestical focused biopharmaceutical company

Question 21

what is structure therapeutics

Answer 21

clinical stage global biopharma specializing in orally
available small molecules targeting G-Coupled
Protein Receptors (GPCR

Question 22

what is aclaris therapeutics

Answer 22

drug discovery and development kinase inhibitor company

Question 23

what is aclaris platform

Answer 23

Kinase inhibition via cystine residues using analysis technology, KINect

Question 24

what is meira gtx

Answer 24

clinical stage gene therapy company

Question 25

what is platform of meiragtx

Answer 25

use gene therapy to customize many vector elements to design a product candidate specific to the disease being targeted (ocular, neurodegenerative and salivary gland diseases) and that allows precise control of gene expression using proprietary oral small molecule inducers

Question 26

what is regenxbio

Answer 26

clinical stahe biotech comp

Question 27

what is platform of regenxbio

Answer 27

NAV® Technology Platform specialized in Adeno-Associated Virus (AVV) Gene Therapy

Question 28

what is vertex pharmaceuticals

Answer 28

bostion based biopharma company focused on rational drug design

Question 29

what is the platform of vertex pharma

Answer 29

small molecule drugs-expertise in structure-based drug design - development of high target therapies.

Question 30

what is ultragenyx pharmaceutical

Answer 30

clinical stage biotech -Treatments for individuals afflicted with rare and ultra-rare genetic disorders such as X-linked hypophosphatemia (XLH), tumor-induced osteomalacia (TIO), osteogenesis imperfecta and others

Question 31

what is platform of ultragenyx pharmaceutical

Answer 31

traditional biologics, small molecules, gene therapies, nucleic acid therapies

Question 32

what is autolus therapeutics

Answer 32

develops car t therapies for cancer patients

Question 33

what is platform autolus therapeutics

Answer 33

CAR T cell therapy company developing advanced autologous T cell therapies, clinical stage programs for hematological and solid tumor indications. (Publications: Nature, Molecular Therapy)

Question 34

what is iovance biotherapeutics

Answer 34

clinical stage biopharmaceutical company with focus on cancer immunotherapiesw

Question 35

what is the platform of iovance

Answer 35

It is mainly based on tumor infiltrating lymphocytes (TIL) therapy that involves isolating T cells from patient’s tumor, expanding them ex vivo and re-infusing them into the patient to target and kill cancer cells.

Question 36

what is sana biotech

Answer 36

Biotechnology company that focuses on engineering cells for hematologic cancers, B-cell mediated autoimmune diseases, and regenerative medicine

Question 37

what is sana biotech platform

Answer 37

engineered CAR T cells, primary islet cells, and iPSCs

Question 38

what is replimune

Answer 38

*Clinical-stage biopharmaceutical company focused on advancing a novel pipeline of cancer immunotherapies centered around oncolytic viruses.

Question 39

what is replimune platform

Answer 39

Cancer immunotherapies through genetically engineering a proprietary oncolytic virus to enhance tumor specificity and increase therapy safety. Virus then modified with therapeutic transgenes to maximize anti-tumor activity. Designed for unmet cancer needs